Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Bausch Health Companies Community
NYSE:BHC Community
1
Narratives
written by author
0
Comments
on narratives written by author
15
Fair Values set
on narratives written by author
Community Investing Ideas
Bausch Health Companies
Popular
Undervalued
Overvalued
Bausch Health Companies
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Gastroenterology Expansion And Global Markets Will Unlock Opportunities
Key Takeaways Strategic acquisitions and late-stage drug development position the company to benefit from rising chronic disease rates and expanding healthcare access globally. Strong operating performance, ongoing deleveraging, and digital sales initiatives improve financial stability, operating margins, and long-term growth prospects.
View narrative
US$7.08
FV
1.2% undervalued
intrinsic discount
0.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
BHC
BHC
Bausch Health Companies
Your Fair Value
US$
Current Price
US$7.00
84.2% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-2b
10b
2015
2018
2021
2024
2025
2027
2030
Revenue US$9.6b
Earnings US$95.0m
Advanced
Set Fair Value